Acquisition of Genera d.d.

RNS Number : 9497C

Dechra Pharmaceuticals PLC

21 October 2015

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Closing of the Takeover Offer for the shares in Genera d.d ("Genera")

and

Completion of the acquisition of shares not owned by Mr Marijan Hanžeković ("Takeover Offer")

LONDON: 21 October 2015: Dechra is pleased to announce that on the closing date of its Takeover Offer to acquire the shares in Genera not owned by Mr Marijan Hanžeković the Company had received valid acceptances in respect of 382,390 Genera shares, amounting to 20.73% of Genera's share capital.

Accordingly, the agreement with Mr. Marijan Hanžeković, the majority shareholder in Genera, to acquire his 63.3% holding (equivalent to 69% voting rights) has become unconditional.  The majority shares were transferred on 20 October 2015 and the minority shares on 21 October. Dechra now owns 1,549,417 shares in Genera, amounting to 92.26% of the voting rights (83.99% of the share capital) of Genera.

With effect from today, Dechra has taken formal control of Genera and it is the Company's intention to delist Genera from the Zagreb Stock Exchange.  To date, the aggregate cost of acquiring the 92.26% controlling interest in Genera has been €36.6 million which has been has been funded from Dechra's existing cash and debt facilities.

Enquiries:
Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer	Mobile: [phone]
Anne-Francoise Nesmes, Chief Financial Officer e-mail: [e-mail]	Mobile: [phone] Office: [phone]
TooleyStreet Communications Ltd
Fiona Tooley, Director e-mail: [e-mail]	Office: [phone] Mobile: [phone]

About Dechra

London Stock Exchange: Full Listing (Pharmaceuticals): Stock code: DPH

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. 

For more information please visit: www.dechra.com

Trademarks: Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

About Genera

Genera is the oldest and largest manufacturer of animal health products in the Republic of Croatia with a strong market share in its local market and neighbouring countries. It operates three main divisions: Animal Health, which represents the majority of revenue, Agrochemicals and Human Pharmaceuticals.  Over the last few years, vaccines have become a key part of the Animal Health Division. Genera has invested significantly in building its poultry vaccines capabilities, including regulatory submissions in the EU and elsewhere.  It operates from one manufacturing location in Kalinovica, Croatia and employs 287 people.

For more information, please visit: www.genera.hr 

 

END

 

 

ACQPKDDDCBDKCKB